Chronic kidney disease: A risk factor for cardiovascular disease

Cardiology Clinics

Volumn 23, Issue 3, 2005, Pages 343-362

  Wali, Ravinder K ^a   Henrich, William L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; ANEMIA; ANTIHYPERTENSIVE THERAPY; ARTERIOSCLEROSIS; BLOOD VESSEL CALCIFICATION; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; DATA ANALYSIS; DATA BASE; DIABETES MELLITUS; DIALYSIS; DISEASE COURSE; DISEASE MARKER; DYSLIPIDEMIA; HEALTH SURVEY; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART VALVE REPLACEMENT; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MANAGED CARE; MICROALBUMINURIA; MITRAL VALVE DISEASE; MORTALITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POPULATION; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; STRESS; SUDDEN DEATH; UNITED STATES; UREMIA; VALVULAR HEART DISEASE;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; HUMANS; KIDNEY DISEASES; RENAL DIALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 23244436726     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2005.03.007     Document Type: Review

References (120)

1. A.S. Levey, J.A. Beto, and B.E. Coronado Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? what do we need to learn? where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease Am J Kidney Dis 32 1998 853 906
2. N.B. Shulman, C.E. Ford, and W.D. Hall Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the Hypertension Detection and Follow-Up Program. The Hypertension Detection and Follow-Up Program Cooperative Group Hypertension 13 1989 I80 I93
3. D.S. Keith, G.A. Nichols, and C.M. Gullion Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization Arch Intern Med 164 2004 659 663
4. K/DOQI clinical practice guidelines for chronic kidney disease. Evaluation, classification, and stratification Am J Kidney Dis 39 2002 S49 S52
5. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
6. A.S. Levey, J.P. Bosch, and J.B. Lewis A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470
7. A.S. Levey Clinical practice. Nondiabetic kidney disease N Engl J Med 347 2002 1505 1511
8. G. Remuzzi, A. Schieppati, and P. Ruggenenti Clinical practice. Nephropathy in patients with type 2 diabetes N Engl J Med 346 2002 1145 1151
9. P. Jungers, Z.A. Massy, and T.N. Khoa Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study Nephrol Dial Transplant 12 1997 2597 2602
10. M. Tonelli, C. Bohm, and S. Pandeya Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency Am J Kidney Dis 37 2001 484 489
11. G.M. London, S.J. Marchais, and A.P. Guerin Impairment of arterial function in chronic renal disease: prognostic impact and therapeutic approach Nephrol Dial Transplant 17 Suppl 11 2002 13 15
12. P.S. Klassen, E.G. Lowrie, and D.N. Reddan Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis JAMA 287 2002 1548 1555
13. R.M. Henry, P.J. Kostense, and G. Bos Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn study Kidney Int 62 2002 1402 1407
14. L.F. Fried, M.G. Shlipak, and C. Crump Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals J Am Coll Cardiol 41 2003 1364 1372
15. M.G. Shlipak, L.F. Fried, and C. Crump Cardiovascular disease risk status in elderly persons with renal insufficiency Kidney Int 62 2002 997 1004
16. J.F. Mann, H.C. Gerstein, and J. Pogue Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial Ann Intern Med 134 2001 629 636
17. S.G. Wannamethee, A.G. Shaper, and I.J. Perry Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke Stroke 28 1997 557 563
18. B.F. Culleton, M.G. Larson, and P.W. Wilson Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency Kidney Int 56 1999 2214 2219
19. P. Muntner, J. He, and L. Hamm Renal insufficiency and subsequent death resulting from cardiovascular disease in the united States J Am Soc Nephrol 13 2002 745 753
20. M. Rahman, C.D. Brown, and J. Coresh The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Arch Intern Med 164 2004 969 976
21. A.X. Garg, W.F. Clark, and R.B. Haynes Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I Kidney Int 61 2002 1486 1494
22. P.A. McCullough Cardiorenal risk: an important clinical intersection Rev Cardiovasc Med 3 2002 71 76
23. USRDS The United States renal data system Am J Kidney Dis 42 2003 202 214
24. C.A. Herzog, J.Z. Ma, and A.J. Collins Poor long-term survival after acute myocardial infarction among patients on long-term dialysis N Engl J Med 339 1998 799 805
25. B.L. Kasiske, E.L. Ramos, and R.S. Gaston The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians J Am Soc Nephrol 6 1995 1 34
26. J.R. Rubel, and E.L. Milford The relationship between serum calcium and phosphate levels and cardiac valvular procedures in the hemodialysis population Am J Kidney Dis 41 2003 411 421
27. M. Salgueira, N. del Toro, and R. Moreno-Alba Vascular calcification in the uremic patient: a cardiovascular risk? Kidney Int Suppl 2003 S119 S121
28. A. Baglin, T. Hanslik, and J.N. Vaillant Severe valvular heart disease in patients on chronic dialysis. A five-year multicenter French survey Ann Med Interne (Paris) 148 1997 521 526
29. C.A. Herzog, J.Z. Ma, and A.J. Collins Long-term survival of dialysis patients in the United States with prosthetic heart valves: should ACC/AHA practice guidelines on valve selection be modified? Circulation 105 2002 1336 1341
30. H.C. Gerstein, J.F. Mann, and Q. Yi Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 286 2001 421 426
31. G.L. Bakris Microalbuminuria: what is it? why is it important? what should be done about it? J Clin Hypertens (Greenwich) 3 2001 99 102
32. R.H. Grimm Jr., K.H. Svendsen, and B. Kasiske Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT Research Group. Multiple Risk Factor Intervention Trial Kidney Int Suppl 63 1997 S10 S14
33. B.F. Culleton, M.G. Larson, and P.S. Parfrey Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study Am J Med 109 2000 1 8
34. P. Ruggenenti, V. Gambara, and A. Perna The nephropathy of non-insulin-dependent diabetes: predictors of outcome relative to diverse patterns of renal injury J Am Soc Nephrol 9 1998 2336 2343
35. G. Remuzzi, and T. Bertani Pathophysiology of progressive nephropathies N Engl J Med 339 1998 1448 1456
36. J.S. Yudkin, R.D. Forrest, and C.A. Jackson Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey Lancet 2 1988 530 533
37. C.D. Stehouwer, M.A. Gall, and J.W. Twisk increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death Diabetes 51 2002 1157 1165
38. M.A. Murtaugh, D.R. Jacobs Jr., and X. Yu Correlates of urinary albumin excretion in young adult blacks and whites: the Coronary Artery Risk Development in Young Adults Study Am J Epidemiol 158 2003 676 686
39. D. De Zeeuw, G. Remuzzi, and H.H. Parving Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy Circulation 110 2004 921 927
40. W.F. Keane Metabolic pathogenesis of cardiorenal disease Am J Kidney Dis 38 2001 1372 1375
41. N.K. Hollenberg Aldosterone in the development and progression of renal injury Kidney Int 66 2004 1 9
42. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group Lancet 352 1998 837 853
43. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group N Engl J Med 342 2000 381 389
44. T.H. Hostetter Prevention of end-stage renal disease due to type 2 diabetes N Engl J Med 345 2001 910 912
45. H. Oda, and W.F. Keane Lipid abnormalities in end stage renal disease Nephrol Dial Transplant 13 Suppl 1 1998 45 49
46. S.E. Nissen, E.M. Tuzcu, and P. Schoenhagen Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial JAMA 291 2004 1071 1080
47. C.P. Cannon, E. Braunwald, and C.H. McCabe Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
48. S. Bianchi, R. Bigazzi, and V.M. Campese Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications Am J Kidney Dis 34 1999 973 995
49. T. Demant, C. Mathes, and K. Gutlich A simultaneous study of the metabolism of apolipoprotein b and albumin in nephrotic patients Kidney Int 54 1998 2064 2080
50. G.L. Warwick, H. Waller, and G.A. Ferns Antioxidant vitamin concentrations and LDL oxidation in nephrotic syndrome Ann Clin Biochem 37 Pt 4 2000 488 491
51. F. Kronenberg, A. Lingenhel, and K. Lhotta Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: impact on lipid-lowering therapy? Kidney Int 66 2004 348 354
52. S.L. Seliger, and C.O. Stehman-Breen Are HMG-CoA reductase inhibitors underutilized in dialysis patients? Semin Dial 16 2003 179 185
53. S.L. Seliger, N.S. Weiss, and D.L. Gillen HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients Kidney Int 61 2002 297 304
54. K. Kalantar-Zadeh, G. Block, and M.H. Humphreys Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients Kidney Int 63 2003 793 808
55. K. Iseki, M. Yamazato, and M. Tozawa Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients Kidney Int 61 2002 1887 1893
56. R.M. Bologa, D.M. Levine, and T.S. Parker Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients Am J Kidney Dis 32 1998 107 114
57. National Kidney Foundation, DOQI Work Group. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease Am J Kidney Dis 41 2003 I 91
58. J.H. Brown, B.G. Murphy, and A.F. Douglas Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation Nephron 75 1997 277 282
59. S. Aakhus, K. Dahl, and T.E. Wideroe Hyperlipidaemia in renal transplant patients J Intern Med 239 1996 407 415
60. H. Holdaas, B. Fellstrom, and A.G. Jardine Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial Lancet 361 2003 2024 2031
61. D.J. Gordon, J.L. Probstfield, and R.J. Garrison High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies Circulation 79 1989 8 15
62. P. Grutzmacher, W. Marz, and B. Peschke Lipoproteins and apolipoproteins during the progression of chronic renal disease Nephron 50 1988 103 111
63. M. Senti, R. Romero, and J. Pedro-Botet Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure Kidney Int 41 1992 1394 1399
64. E. Hernandez, M. Praga, and C. Alamo Lipoprotein(a) and vascular access survival in patients on chronic hemodialysis Nephron 72 1996 145 149
65. M.M. Avram, A. Antignani, and P. Goldwasser Lipids in diabetic and nondiabetic hemodialysis and CAPD patients ASAIO Trans 34 1988 314 316
66. J.E. Gonyea, and C.F. Anderson Weight change and serum lipoproteins in recipients of renal allografts Mayo Clin Proc 67 1992 653 657
67. R. Fathi, N. Isbel, and L. Short The effect of long-term aggressive lipid lowering on ischemic and atherosclerotic burden in patients with chronic kidney disease Am J Kidney Dis 43 2004 45 52
68. P. Muntner, L.L. Hamm, and J.W. Kusek The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease Ann Intern Med 140 2004 9 17
69. M.J. Stampfer, M.R. Malinow, and W.C. Willett A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians JAMA 268 1992 877 881
70. P.M. Ridker, M. Cushman, and M.J. Stampfer Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
71. J. Danesh, R. Collins, and P. Appleby Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies JAMA 279 1998 1477 1482
72. C. Wanner, J. Zimmermann, and S. Schwedler Inflammation and cardiovascular risk in dialysis patients Kidney Int Suppl 2002 99 102
73. B.P. Oberg, E. McMenamin, and F.L. Lucas Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease Kidney Int 65 2004 1009 1016
74. M.G. Shlipak, L.F. Fried, and C. Crump Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency Circulation 107 2003 87 92
75. R.G. Luke Chronic renal failure - a vasculopathic state 2 N Engl J Med 339 1998 841 843
76. A. Levin Cardiac disease in chronic kidney disease: current understanding and opportunities for change Blood Purif 22 2004 21 27
77. B.C. Astor, D.K. Arnett, and A. Brown Association of kidney function and hemoglobin with left ventricular morphology among African Americans: the Atherosclerosis Risk in Communities (ARIC) Study Am J Kidney Dis 43 2004 836 845
78. R.G. Cumming, P. Mitchell, and J.C. Craig Renal impairment and anaemia in a population-based study of older people Intern Med J 34 2004 20 23
79. B.C. Astor, P. Muntner, and A. Levin Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994) Arch Intern Med 162 2002 1401 1408
80. A. Levin Prevalence of cardiovascular damage in early renal disease Nephrol Dial Transplant 16 Suppl 2 2001 7 11
81. R.N. Foley, P.S. Parfrey, and J.D. Harnett The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease Am J Kidney Dis 28 1996 53 61
82. J. Pascual, J.L. Teruel, and J.L. Moya Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study Clin Nephrol 35 1991 280 287
83. R. Provenzano, L. Garcia-Mayol, and P. Suchinda Once-weekly epoetin alfa for treating the anemia of chronic kidney disease 1 Clin Nephrol 61 2004 392 405
84. D.H. Henry, P. Bowers, and M.T. Romano Epoetin alfa. Clinical evolution of a pleiotropic cytokine 2 Arch Intern Med 164 2004 262 276
85. R.M. Marrades, J. Alonso, and J. Roca Cellular bioenergetics after erythropoietin therapy in chronic renal failure J Clin Invest 97 1996 2101 2110
86. R.M. Marrades, J. Roca, and J.M. Campistol Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure J Clin Invest 97 1996 2092 2100
87. C.J. Parsa, A. Matsumoto, and J. Kim A novel protective effect of erythropoietin in the infarcted heart J Clin Invest 112 2003 999 1007
88. M. Celik, N. Gokmen, and S. Erbayraktar Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury Proc Natl Acad Sci U S A 99 2002 2258 2263
89. L. Wang, Z. Zhang, and Y. Wang Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats Stroke 35 2004 1732 1737
90. D. Ribatti, A. Vacca, and A.M. Roccaro Erythropoietin as an angiogenic factor Eur J Clin Invest 33 2003 891 896
91. R.N. Foley, P.S. Parfrey, and J. Morgan Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy Kidney Int 58 2000 1325 1335
92. A.G. Stack, and R. Saran Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States Am J Kidney Dis 40 2002 1202 1210
93. G.M. London Left ventricular alterations and end-stage renal disease Nephrol Dial Transplant 17 Suppl 1 2002 29 36
94. O. Bech-Hanssen, I. Wallentin, and O. Larsson Reduced left ventricular hypertrophy in type 1 diabetic patients with end-stage renal failure. A comparison between groups investigated 1977-80 and 1991-93 Nephrol Dial Transplant 11 1996 1547 1552
95. S.R. Ferreira, V.A. Moises, and A. Tavares Cardiovascular effects of successful renal transplantation: a 1-year sequential study of left ventricular morphology and function, and 24-hour blood pressure profile Transplantation 74 2002 1580 1587
96. C.A. Herzog Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome Kidney Int Suppl 2003 S197 S200
97. E. Paoletti, C. Specchia, and G. Di Maio The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10 year survey Nephrol Dial Transplant 19 2004 1829 1834
98. C. Zoccali, F.A. Benedetto, and F. Mallamaci Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression Kidney Int 65 2004 1492 1498
99. J.Y. Yeun, R.A. Levine, and V. Mantadilok C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients Am J Kidney Dis 35 2000 469 476
100. A. Irish Cardiovascular disease, fibrinogen and the acute phase response: associations with lipids and blood pressure in patients with chronic renal disease 2 Atherosclerosis 137 1998 133 139
101. P.Y. Scarabin, L. Bara, and S. Ricard Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study Arterioscler Thromb 13 1993 886 891
102. B.H. Prinsen, T.J. Rabelink, and J.J. Beutler Increased albumin and fibrinogen synthesis rate in patients with chronic renal failure Kidney Int 64 2003 1495 1504
103. C. Zoccali, F.A. Benedetto, and F. Mallamaci Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure Eur J Clin Invest 33 2003 561 566
104. A. Losito, K. Kalidas, and S. Santoni Association of interleukin-6 -174G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients Kidney Int 64 2003 616 622
105. J. Himmelfarb, P. Stenvinkel, and T.A. Ikizler The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia Kidney Int 62 2002 1524 1538
106. C. Zoccali, F. Mallamaci, and R. Maas Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients Kidney Int 62 2002 339 345
107. N.D. Wong, J.C. Hsu, and R.C. Detrano Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events Am J Cardiol 86 2000 495 498
108. E.J. Sharples, D. Pereira, and S. Summers Coronary artery calcification measured with electron-beam computerized tomography correlates poorly with coronary artery angiography in dialysis patients Am J Kidney Dis 43 2004 313 319
109. G.M. London, A.P. Guerin, and S.J. Marchais Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality 2 Nephrol Dial Transplant 18 2003 1731 1740
110. M. Matsuoka, K. Iseki, and M. Tamashiro Impact of high Coronary Artery Calcification Score (CACS) on survival in patients on chronic hemodialysis Clin Exp Nephrol 8 2004 54 58
111. G.M. Chertow, S.K. Burke, and P. Raggi Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients Kidney Int 62 2002 245 252
112. S. Achenbach, D. Ropers, and K. Pohle Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation Circulation 106 2002 1077 1082
113. G.M. Chertow, S.K. Burke, and M.A. Dillon Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients Nephrol Dial Transplant 14 1999 2907 2914
114. R.J. Aviles, A.T. Askari, and B. Lindahl Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction N Engl J Med 346 2002 2047 2052
115. M. Mockel, R. Schindler, and L. Knorr Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: a 9-month outcome analysis Nephrol Dial Transplant 14 1999 1489 1495
116. C. deFilippi, S. Wasserman, and S. Rosanio Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis JAMA 290 2003 353 359
117. M.C. Iliou, C. Fumeron, and M.O. Benoit Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis and New Cardiac Markers Evaluation (CHANCE) Study Nephrol Dial Transplant 16 2001 1452 1458
118. M.C. Iliou, C. Fumeron, and M.O. Benoit Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) Study Am J Kidney Dis 42 2003 513 523
119. J. Coresh, B.C. Astor, and T. Greene Prevalence of chronic kidney disease and decreased kidney function in the adult us population: third National Health and Nutrition Examination Survey Am J Kidney Dis 41 2003 1 12
120. G. Eknoyan On the epidemic of cardiovascular disease in patients with chronic renal disease and progressive renal failure: a first step to improve the outcomes Am J Kidney Dis 32 1998 S1 S4